Пошук по сайту
Авторизація
Логин:
Пароль:
Регистрация
Забыли свой пароль?
Періодика
Медична інформатика та інженерія
Партнери
Поиск информации по диагнозу / Med And Me Первый украинский нефрологический сайт проф. Д. Иванова Zepter
Технічна підтримка
Ми в соц. мережах
Google+

Американський ринок терапії еректильної дисфункції (U.S. Erectile Dysfunction Therapies Market)




Erectile dysfunction (ED) is estimated to affect more than 150 million men worldwide and the number of men with ED is expected to double by the year 2030. Although most cases are not reported, it is estimated that more than 30 million men affected in the United States (U.S).

While ED is more common in men older than age 65, most men older than age 40 experience occasional difficulty; it is estimated that more than 50% of men older than age 40 report periodic episodes of ED. Despite the high number of cases, impotence is greatly undertreated, with only an estimated 15% of men seeking help from a physician due to the fact that they view the condition as personal or embarrassing.

Since the launch of Pfizer’s oral drug Viagra (sildenafil) in 1998, there has been a considerable increase in public awareness of ED due to extensive marketing by leading drug manufacturers. As a result, the worldwide market for oral ED drugs has reached more than $4.2 billion.

The U.S. market for ED therapies (defined in this report as including prescription ED drugs and penile implants) is expected to continue stable, moderate growth over the next 5 years. Valued at more than $1.9 billion in 2010, the market is expected to increase at a healthy compound annual rate of 5.1%, with sales reaching more than $2.5 billion in 2015. The U.S. ED therapies market is expected to benefit not only from continued strong demand but from highly positive demographic trends, including a large, growing ED population, strong advertising/marketing, emerging next-generation ED therapies, launch of several lower cost generic drugs, and the continued adoption of improved penile implant systems.

This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging drugs, technology and opportunities. Covered topics in this report include erectile dysfunction drugs (existing and emerging oral and topical ED therapies), injectable and intraurethral agents, vacuum constriction devices, penile implants, and alternative treatments.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i. Causes and Prevention

ii. Diagnosis and Treatment

a. Oral Drug Therapy
b. Injectable and Intraurethral Drug Therapy
c. Vacuum Pump Therapy
d. Surgery/Penile Prosthesis Implantation

iii. Erectile Dysfunction Therapies Market

a. Drug Therapy
b. Penile Implants

iv. Methodology

Exhibit ES-1: Erectile Dysfunction Therapies, Combined Market Forecast, 2010-2015

1. CLINICAL OVERVIEW OF ERECTILE DYSFUNCTION

1.1 Causes and Prevention
1.2 Diagnosis and Treatment
1.2.1 Oral Drug Therapy
1.2.2 Injectable and Intraurethral Drug Therapy
1.2.3 Vacuum Pump Therapy
1.2.4 Surgery/Penile Prosthesis Implantation
1.3 Emerging Treatments

2. ERECTILE DYSFUNCTION THERAPIES MARKET

2.1 Drug Therapy
2.1.1 Oral Agents
2.1.1.1 Eli Lilly
2.1.1.2 Bayer HealthCare/Bayer
2.1.1.3 Pfizer
2.1.2 Injectable and Intraurethral Agents
2.1.2.1 Pfizer
2.1.2.2 Meda Pharmaceticals/Meda
2.1.3 Emerging Drugs
2.1.3.1 Oral Agents
2.1.3.1.1 Dong-A PharmTech/Dong-A Pharmaceutical
2.1.3.1.2 Palatin Technologies
2.1.3.1.3 Sanofi-aventis
2.1.3.1.4 SK Chemicals/SK Group
2.1.3.1.5 Vivus
2.1.3.1.6 Discontinued Clinical Development Programs
2.1.3.1.6.1 NitroMed
2.1.3.1.6.2 Novartis
2.1.3.1.6.3 Pfizer
2.1.3.2 Topical Agents
2.1.3.2.1 Futura Medical
2.1.3.2.2 Apricus Biosciences
2.1.4 Alternative Treatments
2.1.4.1 Pomegranate Extract
2.1.4.2 Testosterone Replacement Therapy
2.1.4.3 Yohimbine
2.1.4.4 Over-the-Counter Herbal Treatments
2.2 Penile Implants
2.2.1 Inflatable Implants
2.2.1.1 American Medical Systems/Endo Pharmaceuticals
2.2.1.2 Coloplast
2.2.2 Noninflatable Implants
2.2.2.1 American Medical Systems/Endo Pharmaceuticals
2.2.2.2 Coloplast
2.3 Vacuum Constriction Devices
2.3.1 Augusta Medical Systems
2.3.2 Timm Medical Technologies/Actient Pharmaceuticals
2.3.3 Post-T-Vac Medical
2.4 Market Analysis
2.4.1 Drug Therapy Market
2.4.1.1 Patient Volumes
2.4.1.2 Market Forecast
2.4.1.3 Competitive Analysis
2.4.2 Penile Implants Market
2.4.2.1 Procedure Volumes
2.4.2.2 Market Forecast
2.4.2.3 Competitive Analysis
Exhibit 2-1: Comparative Advantages and Disadvantages of Cialis, Levitra, STAXYN, and Viagra
Exhibit 2-2: Erectile Function Improvement Using Low-Dose Once-Daily Cialis
Exhibit 2-3: Erectile Function Improvement Using Low-Dose Once-Daily Cialisin Patients with Diabetes
Exhibit 2-4: Erectile Function Improvement Using Low-Dose Once-Daily Cialis in Patients with Controlled Hypertension or Cardiovascular Disease
Exhibit 2-5: Erection Confidence Improvement Using Low-Dose Once-Daily Cialis
Exhibit 2-6: Common Adverse Events Associated with the Use of Low-Dose Once-Daily Cialis
Exhibit 2-7: Erectile Function Improvement Using High-Dose Cialis
Exhibit 2-8: Erectile Function Improvement Using High-Dose Cialis in Patients with Diabetes
Exhibit 2-9: Erectile Function Improvement Using High-Dose Cialis in Patients with Controlled Hypertension or Cardiovascular Disease
Exhibit 2-10: Erection Confidence Improvement Using High-Dose Cialis
Exhibit 2-11: Common Adverse Events Associated with the Use of High-Dose Cialis
Exhibit 2-12: STAXYN Orally Disintegrating Tablets
Exhibit 2-13: Common Adverse Events Associated with the Use of STAXYN
Exhibit 2-14: Erectile Function Improvement Using Viagra, Pivotal Efficacy Results
Exhibit 2-15: Steps Involved in the Use of the MUSE Transurethral System
Exhibit 2-16: 2011, Selected Emerging Erectile Dysfunction Products
Exhibit 2-17: Benefits and Risks of Penile Implants
Exhibit 2-18: Advantages and Disadvantages of the AMS 700 Inflatable Penile Implant
Exhibit 2-19: The AMS 700 LGX Inflatable Penile Implant
Exhibit 2-20: Advantages and Disadvantages of the AMS Ambicor Inflatable Penile Implant
Exhibit 2-21: The Titan and Titan OTR Inflatable Penile Prostheses
Exhibit 2-22: The Genesis Flexible Rod Implant
Exhibit 2-23: The SOMAerectStf Vacuum Constriction Device
Exhibit 2-24: The Vitality OTC Vacuum Constriction Device
Exhibit 2-25: The Osbon ErecAid Vacuum Therapy System
Exhibit 2-26: The BOSS 2000-3 and MVP 700 Vacuum Constriction Devices
Exhibit 2-27: Erectile Dysfunction Drug Therapy, Patient Volumes Forecast, 2010-2015
Exhibit 2-28: Erectile Dysfunction Drug Therapy, Market Forecast, 2010-2015
Exhibit 2-29: 2010, Erectile Dysfunction Drug Therapy Market, Share by Supplier
Exhibit 2-30: Penile Prosthesis Implantation, Procedure Volumes Forecast, 2010-2015
Exhibit 2-31: Penile Implants, Market Forecast, 2010-2015
Exhibit 2-32: 2010, Penile Implants Market, Share by Supplier

3. COMPANY PROFILES

3.1 American Medical Systems, Inc./Endo Pharmaceuticals Holdings, Inc.
3.2 Apricus Biosciences, Inc.
3.3 Bayer AG
3.4 Futura Medical PLC
3.5 Eli Lilly and Company
3.6 Pfizer, Inc.
3.7 Reckitt Benckiser PLC
3.8 Vivus, Inc.
Publisher: Medtech Insight
Перекладач: translate.google.com
Американський ринок терапії еректильної дисфункції (U.S. Erectile Dysfunction Therapies Market)
Американський ринок терапії доброякісної гіперплазії передміхурової залози мінімально інвазивним методом (U.S. Minimally Invasive Benign Prostatic Hyperplasia Therapy Systems Market)
Американський ринок терапії нетримання сечі мінімально інвазивним методом (U.S. Minimally Invasive Urinary Incontinence Therapy Systems Market)
Американські ринки приладів загальної та ендоскопічної тазової хірургії (U.S. Markets for General and Pelvic Endoscopic Surgery Products)
Новини
21.04.2018  Відкриття: прогулянки запобігають серцевій недостатності у жінок
21.04.2018  Неврологи розповіли, чому вагітним так важливо харчуватися правильно
21.04.2018  Кішки офіційно визнані "лікувальними тваринами"
21.04.2018  Вчений представив препарат, що знижує тягу до алкогольних напоїв
21.04.2018  Гени змушують дітей перекушувати шкідливими продуктами
21.04.2018  Зелені насадження позитивно впливають на розвиток мозку дітей
20.04.2018  Дослідники виявили понад 500 генів, пов'язаних з інтелектом
20.04.2018  Тренування мозку - ключ до перемоги над дислексією
20.04.2018  Співчуття закладено в генах, з'ясували фахівці
20.04.2018  Шизофренію пов'язали з дитячими травмами
20.04.2018  Протираковий препарат допоможе в боротьбі з аутизмом
19.04.2018  Лікарі готуються до світової епідемії "захворювання Х"
19.04.2018  Розроблено новий засіб проти раку передміхурової залози
19.04.2018  Виявлено нові гени, що запобігають раку
19.04.2018  Компонент слини допоможе впоратися з діареєю мандрівника
19.04.2018  Брудне повітря виявилося небезпечнішим поганої спадковості
18.04.2018  Вчені знайшли в мозку рецептор, пов'язаний з депресією
18.04.2018  Стовбурові клітини допоможуть впоратися з передчасною менопаузою
18.04.2018  Діагностувати рак простати стане не тільки простіше, але і дешевше
18.04.2018  Фахівці виявили світові центри виробництва медичної марихуани
HINARI
PubMed